This task force does not recommend universal, instrument-based screening for perinatal depression because we lack clear evidence that screening improves outcomes.
Family history of psychiatric illness, especially bipolar disorder, was associated with a signifiant increase in risk for postpartum depression.
Changes in maternal sleep and circadian rhythms during pregnancy are associated with infant sleep problems and maternal depression and anxiety.
Risk of PPD is low in women who successfully conceive.
Zuranolone has antidepressant effects in women with severe PPD, observed as early as 3 days after initiation of treatment. Â
Using a wearable device to track daily symptoms of postpartum depression was viewed as acceptable and clinically useful by participants and clinicians.
Interested in telling your story or know of others who wish to share their PPD journey? We seek those who may be interested in participating in the documentary in some capacity.
Intravenous ketamine at delivery reduced risk for postpartum depression; however, only in women at high risk for PPD.
Intranasal oxytocin improves mood in postpartum women but has no impact on mood in women with more severe depressive symptoms.
About 60% of women with mood disorders experience premenstrual exacerbation or PME of their mood during the premenstrual phase of their cycle.
